Total planned funding: $431,298,905
Clear active filters
FHI 360
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
Mozambique | $100,882,972 |
Nigeria | $83,241,227 |
Kenya | $37,296,808 |
South Africa | $33,218,885 |
Zambia | $23,560,648 |
Burundi | $15,170,567 |
India | $12,225,228 |
Vietnam | $11,388,452 |
Indonesia | $10,471,188 |
Democratic Republic of the Congo | $10,181,220 |
Zimbabwe | $9,902,898 |
Côte d'Ivoire | $9,791,203 |
Papua New Guinea | $9,690,171 |
Asia Regional Program | $7,127,614 |
Angola | $6,939,597 |
Uganda | $6,921,485 |
Botswana | $6,749,723 |
Tanzania | $5,452,881 |
Malawi | $5,225,205 |
Caribbean Region | $5,044,985 |
Eswatini | $3,442,089 |
Haiti | $2,906,495 |
South Sudan | $2,841,024 |
Ethiopia | $2,325,314 |
Central America Region | $2,283,457 |
Cambodia | $2,025,000 |
Dominican Republic | $1,868,747 |
Rwanda | $1,713,822 |
Namibia | $450,000 |
Cameroon | $360,000 |
Central Asia Region | $350,000 |
Lesotho | $250,000 |
Ghana | $0 |
Organizational Types
NGO | $431,298,905 |
Program Areas
Treatment | $134,436,767 |
Care | $126,265,934 |
Prevention | $82,461,287 |
Testing | $50,375,083 |
Governance and Systems | $37,759,834 |
Budget Codes
HTXS: Treatment: Adult Treatment | $126,159,913 |
HKID: Care: Orphans and Vulnerable Children | $63,010,161 |
HVOP: Sexual Prevention: Other Sexual Prevention | $51,984,416 |
HVCT: Testing: HIV Testing and Counseling | $50,375,083 |
HBHC: Care: Adult Care and Support | $45,204,909 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $20,996,721 |
HVSI: Strategic Information | $13,947,379 |
OHSS: Health Systems Strengthening | $13,471,317 |
HLAB: Laboratory Infrastructure | $10,341,138 |
HVTB: Care: TB/HIV | $9,332,776 |
PDCS: Care: Pediatric Care and Support | $8,718,088 |
PDTX: Treatment: Pediatric Treatment | $8,276,854 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $5,463,973 |
CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $2,337,426 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $618,946 |
HMIN: Biomedical Prevention: Injection Safety | $546,444 |
HMBL: Biomedical Prevention: Blood Safety | $513,361 |
HTXD: Treatment: ARV Drugs | $0 |
Top Partner Programs
FHI 360:
$431,298,905
View countries